Fortrea Holdings Inc. (FTRE)
NASDAQ · Services · Services-medical laboratories
$19.89−$0.1300 (−0.65%) on the dayAs of the close; data may be delayed.
FTRE price, last 12 months
Key stats
- Previous close
- $20.02
- Open
- $19.90
- Day range
- $19.35 – $20.29
- 52-week range
- $8.31 – $21.39
- Volume
- 708.9K
- Avg volume (20 days)
- 1.4M
- Market cap
- $1.9B
Performance
1W−0.2%
1M+7.3%
3M+12.7%
6M+108.3%
YTD+15.3%
1Y+110.0%
vs S&P 500, 1Y+93.3 pts
Technicals and fundamentals
About Fortrea Holdings Inc.
Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion.
- Sector
- Services
- Industry
- Services-medical laboratories
- Listed on
- NASDAQ
- Market cap
- $1.9B